Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy

Molecular Cancer Therapeutics

Volumn 2, Issue 7, 2003, Pages 685-698

  Lockhart, A Craig ^a   Tirona, Rommel G ^a   Kim, Richard B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER;

DRUG EFFECT; DRUG THERAPY; GENE EXPRESSION; GENETIC VARIABILITY; GENETICS; HUMAN; NEOPLASM; PHARMACOGENETICS; REVIEW;

ATP-BINDING CASSETTE TRANSPORTERS; DRUG THERAPY; GENE EXPRESSION; HUMANS; NEOPLASMS; PHARMACOGENETICS; VARIATION (GENETICS);

EID: 2142799057     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Review

References (188)

1. Allikmets, R., Gerrard, B., Hutchinson, A., and Dean, M. Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database. Hum. Mol. Genet., 5: 1649-1655, 1996. (Pubitemid 26328884)
2. Higgins, C. F. ABC transporters: from microorganisms to man, Annu. Rev. Cell Biol., 8: 67-113, 1992. (Pubitemid 23000992)
3. Dean, M., Hamon, Y., and Chimini, G. The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res., 42: 1007-1017, 2001. (Pubitemid 32645780)
4. Klein, I., Sarkadi, B., and Varadi, A. An inventory of the human ABC proteins. Biochim. Biophys. Acta, 1461: 237-262, 1999.
5. Traut, T. W. The functions and consensus motifs of nine types of peptide segments that form different types of nucleotide-binding sites. Eur. J. Biochem., 222: 9-19, 1994. (Pubitemid 24161319)
6. Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. Distantly related sequences in the α- and β-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J., 1: 945-951, 1982.
7. Nikaido, H., and Hall, J. A. Overview of bacterial ABC transporters. Methods Enzymol., 292: 3-20, 1998. (Pubitemid 29343875)
8. Hipfner, D. R., Almquist, K. C., Leslie, E. M., Gerlach, J. H., Grant, C. E., Deeley, R. G., and Cole, S. P. Membrane topology of the multidrug resistance protein (MRP). A study of glycosylation-site mutants reveals an extracytosolic NH2 terminus. J. Biol. Chem., 272: 23623-23630, 1997. (Pubitemid 27410934)
9. Doige, C. A., and Ames, G. F. ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance. Annu. Rev. Microbiol., 47: 291-319, 1993. (Pubitemid 23302936)
10. Speicher, L. A., Sheridan, V. R., Godwin, A. K., and Tew, K. D. Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype. Br. J. Cancer, 64: 267-273, 1991.
11. Laing, N. M., Belinsky, M. G., Kruh, G. D., Bell, D. W., Boyd, J. T., Barone, L., Testa, J. R., and Tew, K. D. Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells. Cancer Res., 58: 1332-1337, 1998. (Pubitemid 28193584)
12. Luciani, M. F., Denizot, F., Savary, S., Mattei, M. G., and Chimini, G. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics, 21: 150-159, 1994. (Pubitemid 24157738)
13. Vulevic, B., Chen, Z., Boyd, J. T., Davis, W., Jr., Walsh, E. S., Belinsky, M. G., and Tew, K. D. Cloning and characterization of human adenosine 5′-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2). Cancer Res., 61: 3339-3347, 2001. (Pubitemid 32695023)
14. Kaminski, W. E., Piehler, A., Pullmann, K., Porsch-Ozcurumez, M., Duong, C., Bared, G. M., Buchler, C., and Schmitz, G. Complete coding sequence, promoter region, and genomic structure of the human ABCA2 gene and evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun., 281: 249-258, 2001. (Pubitemid 32924427)
15. Dano, K. Development of resistance to daunomycin (NSC-82151) in Ehrlich ascites tumor. Cancer Chemother. Rep., 55: 133-141, 1971.
16. Juliano, R. L., and Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 455: 152-162, 1976.
17. Chen, C. J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., and Roninson, I. B. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell, 47: 381-389, 1986. (Pubitemid 17210152)
18. Borst, P., Schinkel, A. H., Smit, J. J., Wagenaar, E., Van Deemter, L., Smith, A. J., Eijdems, E. W., Baas, F., and Zaman, G. J. Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol. Ther., 60: 289-299, 1993. (Pubitemid 24117380)
19. Brinkmann, U., and Eichelbaum, M. Polymorphisms in the ABC drug transporter gene MDR1. Pharmacogenomics J., 1: 59-64, 2001. (Pubitemid 33757984)
20. Ling, V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol., 40: S3-S8, 1997.
21. Schinkel, A. H. The physiological function of drug-transporting P-glycoproteins. Semin. Cancer Biol., 8: 161-170, 1997. (Pubitemid 28041013)
22. Ueda, K., Yoshida, A., and Amachi, T. Recent progress in P-glycoprotein research. Anti-Cancer Drug Design., 14: 115-121, 1999. (Pubitemid 29292308)
23. Gros, P., Croop, J., and Housman, D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell, 47: 371-380, 1986. (Pubitemid 17210151)
24. Rosenberg, M. F., Callaghan, R., Ford, R. C., and Higgins, C. F. Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J. Biol. Chem., 272: 10685-10694, 1997. (Pubitemid 27181079)
25. Loo, T. W., and Clarke, D. M. Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12. J. Biol. Chem., 272: 20986-20989, 1997. (Pubitemid 27373952)
26. Loo, T. W., and Clarke, D. M. Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates. J. Biol. Chem., 271: 27482-27487, 1996. (Pubitemid 26367309)
27. Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., and Pastan, I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA, 84: 265-269, 1987. (Pubitemid 17013615)
28. Holzmayer, T. A., Hilsenbeck, S., Von Hoff, D. D., and Roninson, I. B. Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas. J. Natl. Cancer Inst. (Bethesda), 84: 1486-1491, 1992.
29. Pirker, R., Wallner, J., Geissler, K., Linkesch, W., Haas, O. A., Bettelheim, P., Hopfner, M., Scherrer, R., Valent, P., and Havelec, L. MDR1 gene expression and treatment outcome in acute myeloid leukemia. J. Natl. Cancer Inst. (Bethesda), 83: 708-712, 1991.
30. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., and Willingham, M. C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA, 84: 7735-7738, 1987.
31. Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., and Bertino, J. R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA, 86: 695-698, 1989. (Pubitemid 19037807)
32. Fisher, G. A., and Sikic, B. I. Clinical studies with modulators of multidrug resistance. Hematol. Oncol. Clin. N. Am., 9: 363-382, 1995.
33. Kerr, D. J., Graham, J., Cummings, J., Morrison, J. G., Thompson, G. G., Brodie, M. J., and Kaye, S. B. The effect of verapamil on the pharmacokinetics of Adriamycin. Cancer Chemother. Pharmacol., 18: 239-242, 1986. (Pubitemid 17007740)
34. Lum, B. L., Kaubisch, S., Yahanda, A. M., Adler, K. M., Jew, L., Ehsan, M. N., Brophy, N. A., Halsey, J., Gosland, M. P., and Sikic, B. I. Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a Phase I trial to modulate multidrug resistance. J. Clin. Oncol., 10: 1635-1642, 1992. (Pubitemid 23057994)
35. Lee, E. J., George, S. L., Caligiuri, M., Szatrowski, T. P., Powell, B. L., Lemke, S., Dodge, R. K., Smith, R., Baer, M., and Schiffer, C. A. Parallel Phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of Cancer and Leukemia Group B Study 9420. J. Clin. Oncol., 17: 2831-2839, 1999. (Pubitemid 29415241)
36. Sonneveld, P., Marie, J. P., Huisman, C., Vekhoff, A., Schoester, M., Faussat, A. M., van Kapel, J., Groenewegen, A., Charnick, S., Zittoun, R., and Lowenberg, B. Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone), in refractory multiple myeloma. A phase I study. Leukemia (Baltimore), 10: 1741-1750, 1996. (Pubitemid 26380020)
37. Tolcher, A. W., Cowan, K. H., Solomon, D., Ognibene, F., Goldspiel, B., Chang, R., Noone, M. H., Denicoff, A. M., Barnes, C. S., Gossard, M. R., Fetsch, P. A., Berg, S. L., Balis, F. M., Venzon, D. J., and O'Shaughnessy, J. A. Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer. J. Clin. Oncol., 14: 1173-1184, 1996. (Pubitemid 26105524)
38. List, A. F., Kopecky, K. J., Willman, C. L., Head, D. R., Persons, D. L., Slovak, M. L., Dorr, R., Karanes, C., Hynes, H. E., Doroshow, J. H., Shurafa, M., and Appelbaum, F. R. Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group Study. Blood, 98: 3212-3220, 2001.
39. Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., and Brinkmann, U. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. USA, 97: 3473-3478, 2000. (Pubitemid 30183327)
40. Hitzl, M., Drescher, S., van der Kuip, H., Schaffeler, E., Fischer, J., Schwab, M., Eichelbaum, M., and Fromm, M. F. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics, 11: 293-298, 2001. (Pubitemid 32537402)
41. Ameyaw, M. M., Regateiro, F., Li, T., Liu, X., Tariq, M., Mobarek, A., Thornton, N., Folayan, G. O., Githang'a, J., Indalo, A., Ofori-Adjei, D., Price-Evans, D. A., and McLeod, H. L. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics, 11: 217-221, 2001. (Pubitemid 32319871)
42. Kerb, R., Aynacioglu, A. S., Brockmoller, J., Schlagenhaufer, R., Bauer, S., Szekeres, T., Hamwi, A., Fritzer-Szekeres, M., Baumgartner, C., Ongen, H. Z., Guzelbey, P., Roots, I., and Brinkmann, U. The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels. Pharmacogenomics J., 1: 204-210, 2001. (Pubitemid 33756660)
43. Kim, R. B., Leake, B. F., Choo, E. F., Dresser, G. K., Kubba, S. V., Schwarz, U. I., Taylor, A., Xie, H. G., McKinsey, J., Zhou, S., Lan, L. B., Schuetz, J. D., Schuetz, E. G., and Wilkinson, G. R. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther., 70: 189-199, 2001. (Pubitemid 32777772)
44. Fellay, J., Marzolini, C., Meaden, E. R., Back, D. J., Buclin, T., Chave, J. P., Decosterd, L. A., Furrer, H., Opravil, M., Pantaleo, G., Retelska, D., Ruiz, L., Schinkel, A. H., Vernazza, P., Eap, C. B., Telenti, A., and The Swiss HIV Cohort Study. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet, 359: 30-36, 2002. (Pubitemid 34119193)
45. Min, D., and Ellingrod, V. C3435T mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjects. Ther. Drug Monitoring, 24: 400-404, 2002. (Pubitemid 34553206)
46. Calado, R., Falcao, R., Garcia, A., Gabellini, S., Zago, M., and Franco, R. Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells. Haematologica, 87: 564-568, 2002. (Pubitemid 34640637)
47. van den Heuvel-Eibrink, M. M., Wiemer, E. A., de Boevere, M. J., van der Holt, B., Vossebeld, P. J., Pieters, R., and Sonneveld, P. MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia. Blood, 97: 3605-3611, 2001.
48. Illmer, T., Schuler, U. S., Thiede, C., Schwarz, U. I., Kim, R. B., Gotthard, S., Freund, D., Schakel, U., Ehninger, G., and Schaich, M. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res., 62: 4955-4962, 2002. (Pubitemid 34984419)
49. Cole, S. P., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M., and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Wash. DC), 258: 1650-1654, 1992. (Pubitemid 23012438)
50. Cole, S. P., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54: 5902-5910, 1994. (Pubitemid 24375226)
51. Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P., and Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54: 357-361, 1994. (Pubitemid 24053167)
52. Jedlitschky, G., Leier, I., Buchholz, U., Center, M., and Keppler, D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res., 54: 4833-4836, 1994. (Pubitemid 24289409)
53. Muller, M., Meijer, C., Zaman, G. J., Borst, P., Scheper, R. J., Mulder, N. H., de Vries, E. G., and Jansen, P. L. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA, 91: 13033-13037, 1994.
54. Jedlitschky, G., Leier, I., Buchholz, U., Barnouin, K., Kurz, G., and Keppler, D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res., 56: 988-994, 1996. (Pubitemid 26065391)
55. Loe, D. W., Almquist, K. C., Cole, S. P., and Deeley, R. G. ATP-dependent 17β-estradiol 17-(β-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J. Biol. Chem., 271: 9683-9689, 1996.
56. Loe, D. W., Almquist, K. C., Deeley, R. G., and Cole, S. P. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. J. Biol. Chem., 271: 9675-9682, 1996.
57. Loe, D. W., Stewart, R. K., Massey, T. E., Deeley, R. G., and Cole, S. P. ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene. Mol. Pharmacol., 51: 1034-1041, 1997. (Pubitemid 27249137)
58. O'Brien, M. L., and Tew, K. D. Glutathione and related enzymes in multidrug resistance. Eur. J. Cancer, 32A: 967-978, 1996.
59. Zaman, G. J., Lankelma, J., van Tellingen, O., Beijnen, J., Dekker, H., Paulusma, C., Oude Elferink, R. P., Baas, F., and Borst, P. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc. Natl. Acad. Sci. USA, 92: 7690-7694, 1995.
60. Rappa, G., Lorico, A., Flavell, R. A., and Sartorelli, A. C. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res., 57: 5232-5237, 1997. (Pubitemid 27516354)
61. Kast, C., and Gros, P. Epitope insertion favors a six transmembrane domain model for the carboxy-terminal portion of the multidrug resistance-associated protein. Biochemistry, 37: 2305-2313, 1998. (Pubitemid 28119304)
62. Flens, M. J., Zaman, G. J., van der Valk, P., Izquierdo, M. A., Schroeijers, A. B., Scheffer, G. L., van der Groep, P., de Haas, M., Meijer, C. J., and Scheper, R. J. Tissue distribution of the multidrug resistance protein. Am. J. Pathol., 148: 1237-1247, 1996. (Pubitemid 26111082)
63. Nooter, K., Westerman, A. M., Flens, M. J., Zaman, G. J., Scheper, R. J., van Wingerden, K. E., Burger, H., Oostrum, R., Boersma, T., and Sonneveld, P. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin. Cancer Res., 1: 1301-1310, 1995.
64. Kruh, G. D., Gaughan, K. T., Godwin, A., and Chan, A. Expression pattern of MRP in human tissues and adult solid tumor cell lines. J. Natl. Cancer Inst. (Bethesda), 87: 1256-1258, 1995.
65. Kuss, B. J., Deeley, R. G., Cole, S. P., Willman, C. L., Kopecky, K. J., Wolman, S. R., Eyre, H. J., Lane, S. A., Nancarrow, J. K., and Whitmore, S. A. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet, 343: 1531-1534, 1994.
66. Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L., and Haber, M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N. Engl. J. Med., 334: 231-238, 1996. (Pubitemid 26032215)
67. Chan, H. S., Lu, Y., Grogan, T. M., Haddad, G., Hipfner, D. R., Cole, S. P., Deeley, R. G., Ling, V., and Gallie, B. L. Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res., 57: 2325-2330, 1997. (Pubitemid 27255882)
68. Dolfini, E., Dasdia, T., Arancia, G., Molinari, A., Calcabrini, A., Scheper, R. J., Flens, M. J., Gariboldi, M. B., and Monti, E. Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin. Br. J. Cancer, 76: 67-76, 1997. (Pubitemid 27250078)
69. Berger, W., Elbling, L., Hauptmann, E., and Micksche, M. Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells. Int. J. Cancer, 73: 84-93, 1997. (Pubitemid 27445995)
70. Ishikawa, T., Muller, M., Klunemann, C., Schaub, T., and Keppler, D. ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. J. Biol. Chem., 265: 19279-19286, 1990.
71. Barnouin, K., Leier, I., Jedlitschky, G., Pourtier-Manzanedo, A., Konig, J., Lehmann, W. D., and Keppler, D. Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione. Br. J. Cancer, 77: 201-209, 1998. (Pubitemid 28029535)
72. Priebe, W., Krawczyk, M., Kuo, M. T., Yamane, Y., Savaraj, N., and Ishikawa, T. Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. Biochem. Biophys. Res. Commun., 247: 859-863, 1998. (Pubitemid 28418481)
73. Morrow, C. S., Smitherman, P. K., Diah, S. K., Schneider, E., and Townsend, A. J. Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells. J. Biol. Chem., 273: 20114-20120, 1998. (Pubitemid 28377567)
74. Schneider, E., Horton, J. K., Yang, C. H., Nakagawa, M., and Cowan, K. H. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res., 54: 152-158, 1994. (Pubitemid 24042102)
75. Hooijberg, J. H., Broxterman, H. J., Kool, M., Assaraf, Y. G., Peters, G. J., Noordhuis, P., Scheper, R. J., Borst, P., Pinedo, H. M., and Jansen, G. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res., 59: 2532-2535, 1999. (Pubitemid 29269093)
76. Hipfner, D. R., Deeley, R. G., and Cole, S. P. Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta, 1461: 359-376, 1999.
77. Zaman, G. J., Flens, M. J., van Leusden, M. R., de Haas, M., Mulder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., Broxterman, H. J., et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA, 91: 8822-8826, 1994.
78. Peck, R. A., Hewett, J., Harding, M. W., Wang, Y. M., Chaturvedi, P. R., Bhatnagar, A., Ziessman, H., Atkins, F., and Hawkins, M. J. Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin. J. Clin. Oncol., 19: 3130-3141, 2001. (Pubitemid 32565452)
79. Bergen, A. A., Plomp, A. S., Schuurman, E. J., Terry, S., Breuning, M., Dauwerse, H., Swart, J., Kool, M., van Soest, S., Baas, F., ten Brink, J. B., and de Jong, P. T. Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat. Genet., 25: 228-231, 2000. (Pubitemid 30394999)
80. Meloni, I., Rubegni, P., De Aloe, G., Bruttini, M., Pianigiani, E., Cusano, R., Seri, M., Mondillo, S., Federico, A., Bardelli, A. M., Andreassi, L., Fimiani, M., and Renieri, A. Pseudoxanthoma elasticum: point mutations in the ABCC6 gene and a large deletion including also ABCC1 and MYH11. Hum. Mutat., 18: 85-90, 2001.
81. Le Saux, O., Urban, Z., Tschuch, C., Csiszar, K., Bacchelli, B., Quaglino, D., Pasquali-Ronchetti, I., Pope, F. M., Richards, A., Terry, S., Bercovitch, L., de Paepe, A., and Boyd, C. D. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat. Genet., 25: 223-227, 2000. (Pubitemid 30394998)
82. Perdu, J., and Germain, D. P. Identification of novel polymorphisms in the pM5 and MRP1 (ABCC1) genes at locus 16p13.1 and exclusion of both genes as responsible for pseudoxanthoma elasticum. Hum. Mutat., 17: 74-75, 2001.
83. Ito, S., Ieiri, I., Tanabe, M., Suzuki, A., Higuchi, S., and Otsubo, K. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics, 11: 175-184, 2001. (Pubitemid 32216128)
84. Conrad, S., Kauffmann, H. M., Ito, K., Deeley, R. G., Cole, S. P., and Schrenk, D. Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution. J. Hum. Genet., 46: 656-663, 2001. (Pubitemid 33134743)
85. Conrad, S., Kauffmann, H., Ito, K., Leslie, E., Deeley, R., Schrenk, D., and Cole, S. A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance. Pharmacogenetics, 12: 321-330, 2002. (Pubitemid 34620660)
86. Kobayashi, K., Sogame, Y., Hayashi, K., Nicotera, P., and Orrenius, S. ATP stimulates the uptake of S-dinitrophenylglutathione by rat liver plasma membrane vesicles. FEBS Lett., 240: 55-58, 1988. (Pubitemid 19003898)
87. Paulusma, C. C., Bosma, P. J., Zaman, G. J., Bakker, C. T., Otter, M., Scheffer, G. L., Scheper, R. J., Borst, P., and Oude Elferink, R. P. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science (Wash. DC), 271: 1126-1128, 1996. (Pubitemid 26075228)
88. Keppler, D., and Kartenbeck, J. The canalicular conjugate export pump encoded by the cmrp/cmoat gene. Prog. Liver Dis., 14: 55-67, 1996. (Pubitemid 26381335)
89. Keppler, D., and Konig, J. Hepatic secretion of conjugated drugs and endogenous substances. Semin. Liver Dis., 20: 265-272, 2000.
90. Cui, Y., Konig, J., Buchholz, J. K., Spring, H., Leier, I., and Keppler, D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol., 55: 929-937, 1999. (Pubitemid 29214613)
91. Tusnady, G. E., Bakos, E., Varadi, A., and Sarkadi, B. Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters. FEBS Lett., 402: 1-3, 1997. (Pubitemid 27056011)
92. Taniguchi, K., Wada, M., Kohno, K., Nakamura, T., Kawabe, T., Kawakami, M., Kagotani, K., Okumura, K., Akiyama, S., and Kuwano, M. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res., 56: 4124-4129, 1996. (Pubitemid 26305002)
93. Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., Baas, F., and Borst, P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res., 57: 3537-3547, 1997. (Pubitemid 27355505)
94. Minemura, M., Tanimura, H., and Tabor, E. Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines. Int. J. Oncol., 15: 559-563, 1999.
95. Koike, K., Kawabe, T., Tanaka, T., Toh, S., Uchiumi, T., Wada, M., Akiyama, S., Ono, M., and Kuwano, M. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res., 57: 5475-5479, 1997. (Pubitemid 28006750)
96. Masuda, M., I'Izuka, Y., Yamazaki, M., Nishigaki, R., Kato, Y., Ni'inuma, K., Suzuki, H., and Sugiyama, Y. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Cancer Res., 57: 3506-3510, 1997. (Pubitemid 27355499)
97. Ito, K., Oleschuk, C. J., Westlake, C., Vasa, M. Z., Deeley, R. G., and Cole, S. P. Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. J. Biol. Chem., 276: 38108-38114, 2001.
98. Hinoshita, E., Uchiumi, T., Taguchi, K., Kinukawa, N., Tsuneyoshi, M., Maehara, Y., Sugimachi, K., and Kuwano, M. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin. Cancer Res., 6: 2401-2407, 2000. (Pubitemid 30399208)
99. Nies, A. T., Konig, J., Pfannschmidt, M., Klar, E., Hofmann, W. J., and Keppler, D. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma, Int. J. Cancer, 94: 492-499, 2001.
100. Narasaki, F., Oka, M., Nakano, R., Ikeda, K., Fukuda, M., Nakamura, T., Soda, H., Nakagawa, M., Kuwano, M., and Kohno, S. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells. Biochem. Biophys. Res. Commun., 240: 606-611, 1997. (Pubitemid 28271765)
101. Schaub, T. P., Kartenbeck, J., Konig, J., Spring, H., Dorsam, J., Staehler, G., Storkel, S., Thon, W. F., and Keppler, D. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J. Am. Soc. Nephrol., 10: 1159-1169, 1999. (Pubitemid 29246980)
102. Kartenbeck, J., Leuschner, U., Mayer, R., and Keppler, D. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology, 23: 1061-1066, 1996.
103. Tsujii, H., Konig, J., Rost, D., Stockel, B., Leuschner, U., and Keppler, D. Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome. Gastroenterology, 117: 653-660, 1999. (Pubitemid 29409252)
104. Paulusma, C. C., Kool, M., Bosma, P. J., Scheffer, G. L., ter Borg, F., Scheper, R. J., Tytgat, G. N., Borst, P., Baas, F., and Oude Elferink, R. P. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology, 25: 1539-1542, 1997. (Pubitemid 27250780)
105. Keitel, V., Kartenbeck, J., Nies, A. T., Spring, H., Brom, M., and Keppler, D. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology, 32: 1317-1328, 2000.
106. Abe, H., and Okuda, K. Biliary excretion of conjugated sulfobromophthalein (BSP) in constitutional conjugated hyperbilirubinemias. Digestion, 13: 272-283, 1975.
107. Sugiyama, Y., Kato, Y., and Chu, X. Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: role of canalicular multispecific organic anion transporter and P-glycoprotein. Cancer Chemother. Pharmacol., 42: S44-S49, 1998.
108. Toh, S., Wada, M., Uchiumi, T., Inokuchi, A., Makino, Y., Horie, Y., Adachi, Y., Sakisaka, S., and Kuwano, M. Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome. Am. J. Hum. Genet., 64: 739-746, 1999. (Pubitemid 30460416)
109. Kool, M., van der Linden, M., de Haas, M., Scheffer, G. L., de Vree, J. M., Smith, A. J., Jansen, G., Peters, G. J., Ponne, N., Scheper, R. J., Elferink, R. P., Baas, F., and Borst, P. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. USA, 96: 6914-6919, 1999. (Pubitemid 29274984)
110. Hirohashi, T., Suzuki, H., and Sugiyama, Y. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J. Biol. Chem., 274: 15181-15185, 1999.
111. Belinsky, M. G., Bain, L. J., Balsara, B. B., Testa, J. R., and Kruh, G. D. Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. J. Natl. Cancer Inst. (Bethesda), 90: 1735-1741, 1998. (Pubitemid 28539094)
112. Kiuchi, Y., Suzuki, H., Hirohashi, T., Tyson, C. A., and Sugiyama, Y. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Lett., 433: 149-152, 1998. (Pubitemid 28386747)
113. Konig, J., Rost, D., Cui, Y., and Keppler, D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology, 29: 1156-1163, 1999. (Pubitemid 29168750)
114. Scheffer, G. L., Kool, M., de Haas, M., de Vree, J. M., Pijnenborg, A. C., Bosman, D. K., Elferink, R. P., van der Valk, P., Borst, P., and Scheper, R. J. Tissue distribution and induction of human multidrug resistant protein 3. Lab. Investig., 82: 193-201, 2002. (Pubitemid 34160456)
115. Uchiumi, T., Hinoshita, E., Haga, S., Nakamura, T., Tanaka, T., Toh, S., Furukawa, M., Kawabe, T., Wada, M., Kagotani, K., Okumura, K., Kohno, K., Akiyama, S., and Kuwano, M. Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport. Biochem. Biophys. Res. Commun., 252: 103-110, 1998. (Pubitemid 28534634)
116. Hirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T., and Sugiyama, Y. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. Mol. Pharmacol., 53: 1068-1075, 1998. (Pubitemid 28280450)
117. Suzuki, T., Nishio, K., Sasaki, H., Kurokawa, H., Saito-Ohara, F., Ikeuchi, T., Tanabe, S., Terada, M., and Saijo, N. cDNA cloning of a short type of multidrug resistance protein homologue, SMRP, from a human lung cancer cell line. Biochem. Biophys. Res. Commun., 238: 790-794, 1997. (Pubitemid 27472654)
118. Tusnady, G. E., and Varadi, A. Short MRP may not be short. Biochem. Biophys. Res. Commun., 242: 465-466, 1998.
119. Ortiz, D. F., Li, S., Iyer, R., Zhang, X., Novikoff, P., and Arias, I. M. MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte. Am. J. Physiol., 276: G1493-G1500, 1999. (Pubitemid 29323456)
120. Soroka, C. J., Lee, J. M., Azzaroli, F., and Boyer, J. L. Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology, 33: 783-791, 2001. (Pubitemid 32246625)
121. Zeng, H., Bain, L. J., Belinsky, M. G., and Kruh, G. D. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. Cancer Res., 59: 5964-5967, 1999. (Pubitemid 30004958)
122. Young, L. C., Campling, B. G., Voskoglou-Nomikos, T., Cole, S. P., Deeley, R. G., and Gerlach, J. H. Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. Clin. Cancer Res., 5: 673-680, 1999. (Pubitemid 29131979)
123. Young, L. C., Campling, B. G., Cole, S. P., Deeley, R. G., and Gerlach, J. H. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Clin. Cancer Res., 7: 1798-1804, 2001. (Pubitemid 32708651)
124. Schuetz, J. D., Connelly, M. C., Sun, D., Paibir, S. G., Flynn, P. M., Srinivas, R. V., Kumar, A., and Fridland, A. MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat. Med., 5: 1048-1051, 1999. (Pubitemid 29439577)
125. Lai, L., and Tan, T. M. Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem. J., 361: 497-503, 2002. (Pubitemid 34177819)
126. McAleer, M. A., Breen, M. A., White, N. L., and Matthews, N. pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J. Biol. Chem., 274: 23541-23548, 1999.
127. Jedlitschky, G., Burchell, B., and Keppler, D. The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J. Biol. Chem., 275: 30069-30074, 2000.
128. Wijnholds, J., Mol, C. A., van Deemter, L., de Haas, M., Scheffer, G. L., Baas, F., Beijnen, J. H., Scheper, R. J., Hatse, S., De Clercq, E., Balzarini, J., and Borst, P. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc. Natl. Acad. Sci. USA, 97: 7476-7481, 2000. (Pubitemid 30431488)
129. Kool, M., van der Linden, M., de Haas, M., Baas, F., and Borst, P. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res., 59: 175-182, 1999. (Pubitemid 29062975)
130. Scheffer, G. L., Hu, X., Pijnenborg, A. C., Wijnholds, J., Bergen, A. A., and Scheper, R. J. MRP6 (ABCC6) detection in normal human tissues and tumors. Lab. Investig., 82: 515-518, 2002. (Pubitemid 34311123)
131. Madon, J., Hagenbuch, B., Landmann, L., Meier, P. J., and Stieger, B. Transport function and hepatocellular localization of mrp6 in rat liver. Mol. Pharmacol., 57: 634-641, 2000. (Pubitemid 30140896)
132. Ilias, A., Urban, Z., Seidl, T. L., Le Saux, O., Sinko, E., Boyd, C. D., Sarkadi, B., and Varadi, A. Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J. Biol. Chem., 277: 16860-16867, 2002. (Pubitemid 34967710)
133. Belinsky, M. G., Shchaveleva, I., Zeng, H., and Kruh, G. D. Drug-resistance phenotype of multidrug-resistance protein-6-transfected Chinese hamster ovary cells. Proc. Am. Assoc. Cancer Res., 42: 281, 2001.
134. Longhurst, T. J., O'Neill, G. M., Harvie, R. M., and Davey, R. A. The anthracycline resistance-associated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell line. Br. J. Cancer, 74: 1331-1335, 1996. (Pubitemid 26370720)
135. O'Neill, G. M., Peters, G. B., Harvie, R. M., MacKenzie, H. B., Henness, S., and Davey, R. A. Amplification and expression of the ABC transporters ARA and MRP in a series of multidrug-resistant leukaemia cell sublines. Br. J. Cancer, 77: 2076-2080, 1998. (Pubitemid 28263925)
136. Belinsky, M. G., and Kruh, G. D. MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver. Br. J. Cancer, 80: 1342-1349, 1999. (Pubitemid 29308601)
137. Kuss, B. J., O'Neill, G. M., Eyre, H., Doggett, N. A., Callen, D. F., and Davey, R. A. ARA, a novel ABC transporter, is located at 16p13.1, is deleted in inv(16) leukemias, and is shown to be expressed in primitive hematopoietic precursors. Genomics, 51: 455-458, 1998. (Pubitemid 28413213)
138. Borst, P., Evers, R., Kool, M., and Wijnholds, J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. (Bethesda), 92: 1295-1302, 2000. (Pubitemid 30662093)
139. Germain, D. P., Perdu, J., Remones, V., and Jeunemaitre, X. Homozygosity for the R1268Q mutation in MRP6, the pseudoxanthoma elasticum gene, is not disease-causing. Biochem. Biophys. Res. Commun., 274: 297-301, 2000. (Pubitemid 30614314)
140. Bera, T. K., Lee, S., Salvatore, G., Lee, B., and Pastan, I. MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol. Med., 7: 509-516, 2001.
141. Tammur, J., Prades, C., Arnould, I., Rzhetsky, A., Hutchinson, A., Adachi, M., Schuetz, J. D., Swoboda, K. J., Ptacek, L. J., Rosier, M., Dean, M., and Allikmets, R. Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene (Amst.), 273: 89-96, 2001. (Pubitemid 32718730)
142. Yabuuchi, H., Shimizu, H., Takayanagi, S., and Ishikawa, T. Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. Biochem. Biophys. Res. Commun., 288: 933-939, 2001. (Pubitemid 33140973)
143. Bera, T. K., Iavarone, C., Kumar, V., Lee, S., Lee, B., and Pastan, I. MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancer. Proc. Natl. Acad. Sci. USA, 99: 6997-7002, 2002. (Pubitemid 34526246)
144. Dietel, M., Arps, H., Lage, H., and Niendorf, A. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res., 50: 6100-6106, 1990. (Pubitemid 20331427)
145. Dalton, W. S., Cress, A. E., Alberts, D. S., and Trent, J. M. Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. Cancer Res., 48: 1882-1888, 1988.
146. Harker, W. G., Slade, D. L., Dalton, W. S., Meltzer, P. S., and Trent, J. M. Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression. Cancer Res., 49: 4542-4549, 1989. (Pubitemid 19208359)
147. Nakagawa, M., Schneider, E., Dixon, K. H., Horton, J., Kelley, K., Morrow, C., and Cowan, K. H. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells. Cancer Res., 52: 6175-6181, 1992.
148. Lee, J. S., Scala, S., Matsumoto, Y., Dickstein, B., Robey, R., Zhan, Z., Altenberg, G., and Bates, S. E. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression. J. Cell. Biochem., 65: 513-526, 1997. (Pubitemid 27240917)
149. Allikmets, R., Schriml, L. M., Hutchinson, A., Romano-Spica, V., and Dean, M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res., 58: 5337-5339, 1998. (Pubitemid 28551112)
150. Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., and Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA, 95: 15665-15670, 1998. (Pubitemid 29018757)
151. Miyake, K., Mickley, L., Litman, T., Zhan, Z., Robey, R., Cristensen, B., Brangi, M., Greenberger, L., Dean, M., Fojo, T., and Bates, S. E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res., 59: 8-13, 1999. (Pubitemid 29062946)
152. Scheffer, G. L., Maliepaard, M., Pijnenborg, A. C., van Gastelen, M. A., de Jong, M. C., Schroeijers, A. B., van der Kolk, D. M., Allen, J. D., Ross, D. D., van der Valk, P., Dalton, W. S., Schellens, J. H., and Scheper, R. J. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. Cancer Res., 60: 2589-2593, 2000. (Pubitemid 30318229)
153. Brangi, M., Litman, T., Ciotti, M., Nishiyama, K., Kohlhagen, G., Takimoto, C., Robey, R., Pommier, Y., Fojo, T., and Bates, S. E. Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells. Cancer Res., 59: 5938-5946, 1999. (Pubitemid 30004955)
154. Lage, H., and Dietel, M. Effect of the breast-cancer resistance protein on atypical multidrug resistance. Lancet Oncol., 1: 169-175, 2000.
155. Rocchi, E., Khodjakov, A., Volk, E. L., Yang, C. H., Litman, T., Bates, S. E., and Schneider, E. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochem. Biophys. Res. Commun., 271: 42-46, 2000. (Pubitemid 30444853)
156. Ross, D. D., Yang, W., Abruzzo, L. V., Dalton, W. S., Schneider, E., Lage, H., Dietel, M., Greenberger, L., Cole, S. P., and Doyle, L. A. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J. Natl. Cancer Inst. (Bethesda), 91: 429-433, 1999. (Pubitemid 29128278)
157. Jonker, J. W., Buitelaar, M., Wagenaar, E., Van Der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plosch, T., Kuipers, F., Elferink, R. P., Rosing, H., Beijnen, J. H., and Schinkel, A. H. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA, 99: 15649-15654, 2002. (Pubitemid 35403986)
158. Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A. M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., and Sorrentino, B. P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med., 7: 1028-1034, 2001. (Pubitemid 32937383)
159. Scharenberg, C. W., Harkey, M. A., and Torok-Storb, B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood, 99: 507-512, 2002. (Pubitemid 34533085)
160. Steinbach, D., Sell, W., Voigt, A., Hermann, J., Zintl, F., and Sauerbrey, A. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Leukemia (Baltimore), 16: 1443-1447, 2002.
161. Ross, D. D., Karp, J. E., Chen, T. T., and Doyle, L. A. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Blood, 96: 365-368, 2000. (Pubitemid 30456496)
162. Zhou, S., Morris, J. J., Barnes, Y., Lan, L., Schuetz, J. D., and Sorrentino, B. P. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc. Natl. Acad. Sci. USA, 99: 12339-12344, 2002.
163. Imai, Y., Nakane, M., Kage, K., Tsukahara, S., Ishikawa, E., Tsuruo, T., Miki, Y., and Sugimoto, Y. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol. Cancer Ther., 1: 611-616, 2002.
164. Allen, J. D., Jackson, S. C., and Schinkel, A. H. A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for doxorubicin resistance. Cancer Res., 62: 2294-2299, 2002. (Pubitemid 34411707)
165. Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Perez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M., and Bates, S. E. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP- overexpressing cells. Cancer Res., 61: 6635-6639, 2001. (Pubitemid 32896477)
166. Cascorbi, I., Gerloff, T., Johne, A., Meisel, C., Hoffmeyer, S., Schwab, M., Schaeffeler, E., Eichelbaum, M., Brinkmann, U., and Roots, I. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin. Pharmacol. Ther., 69: 169-174, 2001. (Pubitemid 32225417)
167. Tanabe, M., Ieiri, I., Nagata, N., Inoue, K., Ito, S., Kanamori, Y., Takahashi, M., Kurata, Y., Kigawa, J., Higuchi, S., Terakawa, N., and Otsubo, K. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J. Pharmacol. Exp. Ther., 297: 1137-1143, 2001. (Pubitemid 32472514)
168. Decleves, X., Chevillard, S., Charpentier, C., Vielh, P., and Laplanche, J. L. A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein. Hum. Mutat., 15: 486-488, 2000.
169. Rund, D., Azar, I., and Shperling, O. A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease. Adv. Exp. Med. Biol., 457: 71-75, 1999.
170. Mickley, L. A., Lee, J. S., Weng, Z., Zhan, Z., Alvarez, M., Wilson, W., Bates, S. E., and Fojo, T. Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood, 91: 1749-1756, 1998. (Pubitemid 28110341)
171. Kioka, N., Tsubota, J., Kakehi, Y., Komano, T., Gottesman, M. M., Pastan, I., and Ueda, K. P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem. Biophys. Res. Commun., 162: 224-231, 1989. (Pubitemid 19185850)
172. Kimchi-Sarfaty, C., Gribar, J., and Gottesman, M. Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. Mol. Pharmacol., 62: 1-6, 2002. (Pubitemid 34680509)
173. Potocnik, U., Ravnik-Glavac, M., Golouh, R., and Glavac, D. Naturally occurring mutations and functional polymorphisms in multidrug resistance 1 gene: correlation with microsatellite instability and lymphoid infiltration in colorectal cancers. J. Med. Genet., 39: 340-346, 2002. (Pubitemid 34526355)
174. Saito, S., Iida, A., Sekine, A., Miura, Y., Ogawa, C., Kawauchi, S., Higuchi, S., and Nakamura, Y. Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR). J. Hum. Genet., 47: 147-171, 2002. (Pubitemid 34496175)
175. Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafat, J., Oomen, L. C., Paulusma, C. C., Oude Elferink, R. P., Baas, F., Schinkel, A. H., and Borst, P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Investig., 101: 1310-1319, 1998. (Pubitemid 28166828)
176. Kajihara, S., Hisatomi, A., Mizuta, T., Hara, T., Ozaki, I., Wada, I., and Yamamoto, K. A splice mutation in the human canalicular multispecific organic anion transporter gene causes Dubin-Johnson syndrome. Biochem. Biophys. Res. Commun., 253: 454-457, 1998. (Pubitemid 29026723)
177. Wada, M., Toh, S., Taniguchi, K., Nakamura, T., Uchiumi, T., Kohno, K., Yoshida, I., Kimura, A., Sakisaka, S., Adachi, Y., and Kuwano, M. Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum. Mol. Genet., 7: 203-207, 1998. (Pubitemid 28048535)
178. Itoda, M., Saito, Y., Soyama, A., Saeki, M., Murayama, N., Ishida, S., Sai, K., Nagano, M., Suzuki, H., Sugiyama, Y., Ozawa, S., and Sawada Ji, J. Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5′-untranslated region and exon 28. Drug Metab. Dispos., 30: 363-364, 2002. (Pubitemid 34263818)
179. Fromm, M. F., Leake, B., Roden, D. M., Wilkinson, G. R., and Kim, R. B. Human MRP3 transporter: identification of the 5′-flanking region, genomic organization and alternative splice variants. Biochim. Biophys. Acta, 1415: 369-374, 1999. (Pubitemid 29065302)
180. Lee, K., Belinsky, M. G., Bell, D. W., Testa, J. R., and Kruh, G. D. Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer Res., 58: 2741-2747, 1998. (Pubitemid 28311902)
181. Suzuki, T., Sasaki, H., Kuh, H. J., Agui, M., Tatsumi, Y., Tanabe, S., Terada, M., Saijo, N., and Nishio, K. Detailed structural analysis on both human MRP5 and mouse mrp5 transcripts. Gene (Amst.), 242: 167-173, 2000. (Pubitemid 30064502)
182. Ringpfeil, F., Lebwohl, M. G., Christiano, A. M., and Uitto, J. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc. Natl. Acad. Sci. USA, 97: 6001-6006, 2000. (Pubitemid 30367513)
183. Germain, D. P., Remones, V., Perdu, J., and Jeunemaitre, X. Identification of two polymorphisms (c189G>C; c190T>C) in exon 2 of the human MRP6 gene (ABCC6) by screening of Pseudoxanthoma elasticum patients: possible sequence correction? Hum. Mutat., 16: 449-451, 2000.
184. Ringpfeil, F., Nakano, A., Uitto, J., and Pulkkinen, L. Compound heterozygosity for a recurrent 16.5-kb Alu-mediated deletion mutation and single-base-pair substitutions in the ABCC6 gene results in pseudoxanthoma elasticum. Am. J. Hum. Genet., 68: 642-652, 2001. (Pubitemid 32202759)
185. Le Saux, O., Beck, K., Sachsinger, C., Silvestri, C., Treiber, C., Goring, H. H., Johnson, E. W., De Paepe, A., Pope, F. M., Pasquali-Ronchetti, I., Bercovitch, L., Terry, S., and Boyd, C. D. A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum. Am. J. Hum. Genet., 69: 749-764, 2001. (Pubitemid 32868520)
186. Cai, L., Lumsden, A., Guenther, U., Neldner, S., Zach, S., Knoblauch, H., Ramesar, R., Hohl, D., Callen, D., Neldner, K., Lindpaintner, K., Richards, R., and Struk, B. A novel Q378X mutation exists in the transmembrane transporter protein ABCC6 and its pseudogene: implications for mutation analysis in pseudoxanthoma elasticum. J. Mol. Med., 79: 536-546, 2001. (Pubitemid 32905551)
187. Wang, J., Near, S., Young, K., Connelly, P. W., and Hegele, R. A. ABCC6 gene polymorphism associated with variation in plasma lipoproteins. J. Hum. Genet., 46: 699-705, 2001. (Pubitemid 34037330)
188. Zamber, C. P., Lamba, J. K., Yasuda, K., Farnum, J., Thummel, K., Schuetz, J. D., and Schuetz, E. G. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics, 13: 19-28, 2003. (Pubitemid 36135683)